A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine
Clinical trial NCT02959177 · COMPLETED
Trial details
- NCT number
- NCT02959177
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-09
- Primary completion
- 2019-01-18
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.